Abstract

The leaves of Stevia The COVID-19 epidemic has presented serious difficulties for healthcare professionals, especially those working in dentistry and medical facilities. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, is a high-risk infection in hospital settings since it is known to spread via respiratory droplets and aerosols. The purpose of this review paper is to determine whether preprocedural mouthwashes significantly lower the risk of SARS-CoV2 transmission during dental and medical procedures. in addition, antiseptics including Povidone-iodine, CPC, Benzalkonium Chloride, and Aromatic oils may indeed be capable of eliminating SARS-CoV2 by focusing on the virus's lipid envelope, that according in vitro study, as well as clinical experiments indicate that preprocedural mouthwashes potentially help to reduce intraoral viral load and infectivity in COVID-19 patients, but more research is required to verify this. Other infection control methods, such as PPE, high-volume evacuation (HVE), and air filtration, can also assist in minimizing SARS-CoV2 transmission during operations. The RT-qPCR alone is insufficient to determine the effectiveness of preprocedural mouthwashes against SARS-CoV2 transmission. Future research should also take into account employing supplementary techniques to evaluate the effectiveness of preprocedural mouthwashes, such as determining the virus's survival in cell cultures or using animal models to research the virus' transmission. Further research is needed to determine the best combination of infection control measures to reduce SARS-CoV2 transmission in healthcare settings, but preprocedural mouthwashes may be a simple, low-cost strategy to reduce transmission risk during dental and medical procedures, especially in high-risk patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call